The U.S. subsidiary of French gammacamera vendor Sopha Medical is moving to new headquarters. Themove will enable Sopha Medical Systems to consolidate its headquarters,which currently are located in three buildings in Columbia, MD.Sopha will remain in
The U.S. subsidiary of French gammacamera vendor Sopha Medical is moving to new headquarters. Themove will enable Sopha Medical Systems to consolidate its headquarters,which currently are located in three buildings in Columbia, MD.Sopha will remain in Columbia.
Sopha's rapid growth over the last five years has caused thecompany to outgrow its facilities, according to president ColinMcNaught. The company's installed base in the U.S. increased by23% last year to nearly 1000 systems.
The new 40,000-square-foot site will permit Sopha to establisha new equipment service support center, Sopha Medical CustomerResponse Center. The center will be staffed with technical supportengineers and applications specialists and will provide on-linecomputerized customer support.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.